MoU for Commercial Production of Cadalmin

14th February 2013, New Delhi

MoU for Commercial Production of CadalminDr. G. Syda Rao, Director, Central Marine Fisheries Research Institute (CMFRI) and Dr. A.N. Singh, Managing Director, Celestial Biolabs limited, Hyderabad signed a Memorandum of Understanding (MoU) in the gracious presence of Dr. S. Ayyappan, Secretary, DARE and Director General, ICAR for commercial production and marketing of Cadalmin Green Algal extract (CadalminTM GAe).

CadalminTM GAe contains 100% natural marine bioactive anti-inflammatory ingradients from selected marine macroalga by a patented technology. The product is effective to combat arthritic pain and inflammatory diseases in human being. CadalminTM GAe distributed to more than 400 patients suffering with chronic joint pain and arthritis and clinical trial based studies revealed that more than 98% of the respondents consumed CadalminTM GAe were satisfied with the product with about 70-85% relief in joint pain and arthritis. None of the respondents reported any side effects.

MoU for Commercial Production of CadalminMoU for Commercial Production of CadalminMoU for Commercial Production of Cadalmin

Shri Arvind R. Kaushal, Additional Secretary, DARE and Secretary, ICAR, Dr. K.M.L. Pathak, DDG, Animal Science, Dr. M.M. Pandey, DDG, Engineering, Dr. S.K. Datta, DDG, Crop Sciences, Dr. B. Meenakumari, DDG, Fisheries, Dr. Gaya Prasad, ADG, Animal Health and Director, IVRI and Dr AK Vasisth, ADG, PIM/ESM were also present on the occasion.

(Source: NAIP Mass Media Project, DKMA, ICAR)